Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New device aims to get seniors home faster after surgery

NCT ID NCT07514286

Knowledge-focused Sponsor: Rhythm Diagnostic Systems Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a wearable device called MultiSense® can safely monitor elderly patients (65+) at home after major surgery. The goal is to see if it reduces hospital stays and emergency visits. 80 participants will use the device, and researchers will track recovery quality and unplanned hospital returns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : * Patient aged 65 or over * Patient eligible for remote monitoring using the MultiSense® device * No psychiatric illness that would prevent them from giving informed consent or receiving optimal treatment and follow-up care * Subject affiliated with a health insurance scheme * Subject able to read and understand English * Subject who has signed an informed consent form * Subjects indicated for scheduled surgery * Patients indicated for scheduled surgery : * Transverse colectomy, by laparotomy * Hepatic laparoscopy * Laparoscopic or laparoscopic liver surgery (code hlfc or hlfa for procedures) * Hysterectomy * Adnexectomy * Parietal surgery (eventration) * Rectal resection * Right and left colectomy * Stoma closure by direct approach Exclusion Criteria : * Patients already participating in an interventional clinical trial. * Patients subject to legal protection measures, guardianship, curatorship, or deprived of their liberty by judicial or administrative decision. * Patients hospitalised without consent. * Patients unable to complete a questionnaire and without a close relative to assist them in using the solution. * Patients admitted to or residing in a health or social care facility (other than for the surgery itself). * Persons admitted to or residing in a health or social care institution (other than for the surgery itself); * Persons unable to give their free and informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Average length of stay are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Average length of stay Surgery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Bergonié Insititute

    NOT_YET_RECRUITING

    Bordeaux, 33000, France

  • Inter-municipal Hospital Centre of Mont-de-marsan

    NOT_YET_RECRUITING

    Mont-de-Marsan, 40000, France

  • Western Cancer Institute of Angers

    NOT_YET_RECRUITING

    Angers, 49000, France

  • Western Cancer Institute of Nantes

    RECRUITING

    Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.